Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A10115 | 31477174 | Stem Cell Res Ther | Antioxidant-upregulated mesenchymal stem cells reduce inflammation and improve fatty liver disease in diet-induced obesity. | 2019 | Details |
| A10116 | 31477078 | BMC Endocr Disord | Cholecystectomy versus central obesity or insulin resistance in relation to the risk of nonalcoholic fatty liver disease: the third US National Health and Nutrition Examination Survey. | 2019 | Details |
| A10117 | 31475569 | Arch Physiol Biochem | Inactivation of the superoxide dismutase by malondialdehyde in the nonalcoholic fatty liver disease: a combined molecular docking approach to clinical studies. | 2019 | Details |
| A10118 | 31475372 | Aliment Pharmacol Ther | Characteristics, aetiologies and trends of hepatocellular carcinoma in patients without cirrhosis: a United States multicentre study. | 2019 | Details |
| A10119 | 31475226 | Endosc Int Open | EUS-guided gallbladder drainage in patients with cirrhosis: results of a multicenter retrospective study. | 2019 | Details |
| A10120 | 31474798 | Ann Gastroenterol | Prevalence, trends, outcomes, and disparities in hospitalizations for nonalcoholic fatty liver disease in the United States. | 2019 | Details |
| A10121 | 31474792 | Ann Gastroenterol | High prevalence of non-alcoholic fatty liver disease in patients with inflammatory bowel disease receiving anti-tumor necrosis factor therapy. | 2019 | Details |
| A10122 | 31474685 | J Nutr Sci Vitaminol (Tokyo) | Age-Related Alterations of Nonalcoholic Steatohepatitis in Sprague-Dawley Rats Fed a High-Fat and High-Cholesterol Diet. | 2019 | Details |
| A10123 | 31474679 | J Nutr Sci Vitaminol (Tokyo) | Association between Vitamin D Status and Non-Alcoholic Fatty Liver Disease: A Population-Based Study. | 2019 | Details |
| A10124 | 31474633 | Yakugaku Zasshi | [Involvement of the Free Fatty Acid Receptor GPR120/FFAR4 in the Development of Nonalcoholic Steatohepatitis]. | 2019 | Details |
| A10125 | 31474632 | Yakugaku Zasshi | [Role of Angiogenesis and Chronic Inflammation in Fat Hypertrophy in NASH Pathology]. | 2019 | Details |
| A10126 | 31474631 | Yakugaku Zasshi | [Inhibition of Group IVA Phospholipase A2 as a Novel Therapeutic Strategy for Nonalcoholic Steatohepatitis]. | 2019 | Details |
| A10127 | 31474630 | Yakugaku Zasshi | [Overview of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis Management]. | 2019 | Details |
| A10129 | 31473923 | Environ Sci Pollut Res Int | Associations between mercury exposure and the risk of nonalcoholic fatty liver disease (NAFLD) in US adolescents. | 2019 | Details |
| A10130 | 31473746 | Dig Dis | Increased Prevalence of Colorectal Adenomas in Patients with Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study. | 2019 | Details |
| A10131 | 31473346 | Biochim Biophys Acta Mol Cell Biol Lipids | Exercise regulates lipid droplet dynamics in normal and fatty liver. | 2019 | Details |
| A10132 | 31473320 | Metab Eng | Determining contributions of exogenous glucose and fructose to de novo fatty acid and glycerol synthesis in liver and adipose tissue. | 2019 | Details |
| A10133 | 31472960 | Biochem Biophys Res Commun | Knockout of neutrophil elastase protects against western diet induced nonalcoholic steatohepatitis in mice by regulating hepatic ceramides metabolism. | 2019 | Details |
| A10134 | 31472955 | Biochem Biophys Res Commun | Vitexin alleviates non-alcoholic fatty liver disease by activating AMPK in high fat diet fed mice. | 2019 | Details |
| A10135 | 31472085 | Liver Int | Metabolic syndrome, but not non-alcoholic fatty liver disease, increases 10-year mortality: A prospective, community-cohort study. | 2019 | Details |
| A10136 | 31471434 | BMJ Open | The association between a non-invasive hepatic fibrosis score and urolithiasis among non-alcoholic fatty liver disease (NAFLD) patients in China: a cross-sectional study. | 2019 | Details |
| A10137 | 31471139 | Surg Oncol | Hepatic steatosis in patients undergoing resection of colorectal liver metastases: A target for prehabilitation? A narrative review. | 2019 | Details |
| A10138 | 31470861 | Lipids Health Dis | TRIB1 rs17321515 gene polymorphism increases the risk of coronary heart disease in general population and non-alcoholic fatty liver disease patients in Chinese Han population. | 2019 | Details |
| A10139 | 31470786 | Curr Pharm Des | A Mitochondrial Approach to Cardiovascular Risk and Disease. | 2019 | Details |
| A10140 | 31470644 | Cells | The miRFIB-Score: A Serological miRNA-Based Scoring Algorithm for the Diagnosis of Significant Liver Fibrosis. | 2019 | Details |
| A10141 | 31470620 | Molecules | Study of Methionine Choline Deficient Diet-Induced Steatosis in Mice Using Endogenous Fluorescence Spectroscopy. | 2019 | Details |
| A10142 | 31470518 | Biomolecules | Beyond the Scavenging of Reactive Oxygen Species (ROS): Direct Effect of Cerium Oxide Nanoparticles in Reducing Fatty Acids Content in an In Vitro Model of Hepatocellular Steatosis. | 2019 | Details |
| A10143 | 31470414 | Endocr Connect | Insulin resistance associates with hepatic lobular inflammation in subjects with obesity. | 2019 | Details |
| A10144 | 31470288 | Nutr Res | Gnotobiotic mice inoculated with Firmicutes, but not Bacteroidetes, deteriorate nonalcoholic fatty liver disease severity by modulating hepatic lipid metabolism. | 2019 | Details |
| A10145 | 31470247 | J Trace Elem Med Biol | Aluminium levels in hair and urine are associated with overweight and obesity in a non-occupationally exposed population. | 2019 | Details |
| A10146 | 31470068 | J Hepatol | The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - A longitudinal cohort study. | 2019 | Details |
| A10147 | 31470067 | J Hepatol | Transient elastography for screening of liver fibrosis: Cost-effectiveness analysis from six prospective cohorts in Europe and Asia. | 2019 | Details |
| A10148 | 31469911 | Hepatology | hnRNPU/TrkB Defines a Chromatin Accessibility Checkpoint for Liver Injury and Nonalcoholic Steatohepatitis Pathogenesis. | 2020 | Details |
| A10149 | 31469122 | Pol Arch Intern Med | Serum pentraxin 3 concentration in patients with type 2 diabetes and nonalcoholic fatty liver disease. | 2019 | Details |
| A10150 | 31467918 | Biomed Res Int | Abdominal Obesity as a Predictive Factor of Nonalcoholic Fatty Liver Disease Assessed by Ultrasonography and Transient Elastography in Polycystic Ovary Syndrome and Healthy Women. | 2019 | Details |
| A10151 | 31467529 | Int J Endocrinol | Ginsenoside Rg1 Ameliorates Palmitic Acid-Induced Hepatic Steatosis and Inflammation in HepG2 Cells via the AMPK/NF-κB Pathway. | 2019 | Details |
| A10152 | 31467308 | Sci Rep | High-fat and high-cholesterol diet decreases phosphorylated inositol-requiring kinase-1 and inhibits autophagy process in rat liver. | 2019 | Details |
| A10153 | 31467298 | Sci Rep | Gene Expression Predicts Histological Severity and Reveals Distinct Molecular Profiles of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10154 | 31466361 | Int J Environ Res Public Health | Chemical Effect of Bisphenol A on Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A10155 | 31465774 | Biochem Pharmacol | Functions of aryl hydrocarbon receptor (AHR) and CD38 in NAD metabolism and nonalcoholic steatohepatitis (NASH). | 2019 | Details |
| A10156 | 31465069 | Lab Chip | A microfluidic patterned model of non-alcoholic fatty liver disease: applications to disease progression and zonation. | 2019 | Details |
| A10157 | 31464788 | Eur J Gastroenterol Hepatol | The performance of M and XL probes of FibroScan for the diagnosis of steatosis and fibrosis on a Brazilian nonalcoholic fatty liver disease cohort. | 2020 | Details |
| A10160 | 31464779 | Eur J Gastroenterol Hepatol | Performance of noninvasive scores for the diagnosis of advanced liver fibrosis in morbidly obese with nonalcoholic fatty liver disease. | 2020 | Details |
| A10161 | 31464743 | Am J Gastroenterol | Patients With Nonalcoholic Steatohepatitis Experience Severe Impairment of Health-Related Quality of Life. | 2019 | Details |
| A10162 | 31464113 | Korean J Radiol | Quantitative Imaging in Pediatric Hepatobiliary Disease. | 2019 | Details |
| A10163 | 31463669 | J Nat Med | Cynandione A from Cynanchum wilfordii inhibits hepatic de novo lipogenesis by activating the LKB1/AMPK pathway in HepG2 cells. | 2019 | Details |
| A10164 | 31463596 | Surg Today | Postoperative nonalcoholic fatty liver disease is correlated with malnutrition leading to an unpreferable clinical course for pancreatic cancer patients undergoing pancreaticoduodenectomy. | 2019 | Details |
| A10165 | 31463412 | Transl Gastroenterol Hepatol | Emerging medical therapies for non-alcoholic fatty liver disease and for alcoholic hepatitis. | 2019 | Details |
| A10166 | 31462971 | Comput Struct Biotechnol J | Hallmarks of Aging in the Liver. | 2019 | Details |
| A10167 | 31460789 | Am J Physiol Gastrointest Liver Physiol | Liraglutide improves hepatic steatosis and metabolic dysfunctions in a 3-week dietary mouse model of nonalcoholic steatohepatitis. | 2019 | Details |
| A10168 | 31460584 | Arq Gastroenterol | N-ACETYLCYSTEINE AND/OR URSODEOXYCHOLIC ACID ASSOCIATED WITH METFORMIN IN NON-ALCOHOLIC STEATOHEPATITIS: AN OPEN-LABEL MULTICENTER RANDOMIZED CONTROLLED TRIAL. | 2019 | Details |
| A10169 | 31456946 | Front Oncol | Recent Insights Into the Multiple Pathways Driving Non-alcoholic Steatohepatitis-Derived Hepatocellular Carcinoma. | 2019 | Details |
| A10171 | 31455870 | Int J Obes (Lond) | Specific diacylglycerols generated by hepatic lipogenesis stimulate the oncogenic androgen receptor activity in male hepatocytes. | 2019 | Details |
| A10172 | 31455011 | Int J Environ Res Public Health | Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications. | 2019 | Details |
| A10173 | 31454802 | Lifestyle Genom | Four-Week Omega-3 Supplementation in Carriers of the Prosteatotic PNPLA3 p.I148M Genetic Variant: An Open-Label Study. | 2019 | Details |
| A10174 | 31454158 | Mol Nutr Food Res | Tomatidine Reduces Palmitate-Induced Lipid Accumulation by Activating AMPK via Vitamin D Receptor-Mediated Signaling in Human HepG2 Hepatocytes. | 2019 | Details |
| A10175 | 31452288 | Phytother Res | Quercetin improves nonalcoholic fatty liver by ameliorating inflammation, oxidative stress, and lipid metabolism in db/db mice. | 2019 | Details |
| A10177 | 31450746 | Toxins (Basel) | Chronic Low Dose Oral Exposure to Microcystin-LR Exacerbates Hepatic Injury in a Murine Model of Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A10178 | 31449538 | PLoS One | Nonalcoholic fatty liver disease is a risk factor for large-for-gestational-age birthweight. | 2019 | Details |
| A10179 | 31447675 | Front Pharmacol | NAFLD and Diabetes: Two Sides of the Same Coin? Rationale for Gene-Based Personalized NAFLD Treatment. | 2019 | Details |
| A10180 | 31447605 | Malays J Med Sci | The 2017 M Balasegaram Memorial Lecture: The Changing Landscape of Liver Diseases in Malaysia-60 Years On! | 2019 | Details |
| A10182 | 31446562 | Obes Surg | Intraoperative Liver Biopsy During Adolescent Bariatric Surgery: Is It Really Necessary? | 2020 | Details |
| A10183 | 31445275 | Int J Med Inform | Augmented intelligence with natural language processing applied to electronic health records for identifying patients with non-alcoholic fatty liver disease at risk for disease progression. | 2019 | Details |
| A10184 | 31445117 | Magn Reson Imaging | Evaluation of diffusion kurtosis imaging in stratification of nonalcoholic fatty liver disease and early diagnosis of nonalcoholic steatohepatitis in a rabbit model. | 2019 | Details |
| A10185 | 31445019 | Biochem Pharmacol | M3 muscarinic receptor activation reduces hepatocyte lipid accumulation via CaMKKβ/AMPK pathway. | 2019 | Details |
| A10186 | 31444465 | Eur J Clin Nutr | Vitamin D deficiency: prevalence and association with liver disease severity in pediatric nonalcoholic fatty liver disease. | 2019 | Details |
| A10187 | 31443090 | J Physiol Pharmacol | Omentin, vaspin and irisin in chronic liver diseases. | 2019 | Details |
| A10188 | 31442603 | Clin Gastroenterol Hepatol | Volumetric Liver Fat Fraction Determines Grade of Steatosis More Accurately Than Controlled Attenuation Parameter in Patients With Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10189 | 31442319 | Hepatology | Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation. | 2020 | Details |
| A10190 | 31442254 | PLoS One | Mouse models of hereditary hemochromatosis do not develop early liver fibrosis in response to a high fat diet. | 2019 | Details |
| A10191 | 31441967 | Clin Transplant | A review of the use of transient elastography in the assessment of fibrosis and steatosis in the post-liver transplant patient. | 2019 | Details |
| A10192 | 31440998 | Dig Dis Sci | Baseline and Post-treatment 18F-Fluorocholine PET/CT Predicts Outcomes in Hepatocellular Carcinoma Following Locoregional Therapy. | 2019 | Details |
| A10193 | 31440940 | Inflammation | Melanoma Differentiation-Associated Gene 5 Positively Modulates TNF-α-Induced CXCL10 Expression in Cultured HuH-7 and HLE Cells. | 2019 | Details |
| A10194 | 31439237 | Eur J Radiol | Quantification of steatosis in alcoholic and nonalcoholic fatty liver disease: Evaluation of four MR techniques versus biopsy. | 2019 | Details |
| A10195 | 31438932 | BMC Complement Altern Med | Jiang-Zhi granules decrease sensitivity to low-dose CCl4 induced liver injury in NAFLD rats through reducing endoplasmic reticulum stress. | 2019 | Details |
| A10196 | 31438528 | Mar Drugs | Indole-4-carboxaldehyde Isolated from Seaweed, Sargassum thunbergii, Attenuates Methylglyoxal-Induced Hepatic Inflammation. | 2019 | Details |
| A10197 | 31438482 | Int J Environ Res Public Health | Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way. | 2019 | Details |
| A10198 | 31437454 | Gastrointest Endosc | EUS-guided core liver biopsy sampling using a 22-gauge fork-tip needle: a prospective blinded trial for histologic and lipidomic evaluation in nonalcoholic fatty liver disease. | 2019 | Details |
| A10199 | 31437349 | Am J Transplant | Liver transplant for hepatocellular carcinoma in the United States: Evolving trends over the last three decades. | 2019 | Details |
| A10200 | 31436905 | Cancer Med | The impact of socioeconomic status on outcomes in hepatocellular carcinoma: Inferences from primary insurance. | 2019 | Details |
| A10201 | 31436362 | Liver Int | Plasma N-terminal propeptide of type III procollagen accurately predicts liver fibrosis severity in children with non-alcoholic fatty liver disease. | 2019 | Details |
| A10202 | 31435201 | Gastroenterol Hepatol (N Y) | Implications of Nonalcoholic Fatty Liver Disease on Pregnancy and Maternal and Child Outcomes. | 2019 | Details |
| A10203 | 31435171 | World J Gastroenterol | Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease? | 2019 | Details |
| A10204 | 31434683 | Postgrad Med J | Effect of vitamin E in non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomised controlled trials. | 2019 | Details |
| A10205 | 31433301 | J Hepatol | Integrin β1-enriched extracellular vesicles mediate monocyte adhesion and promote liver inflammation in murine NASH. | 2019 | Details |
| A10206 | 31433263 | Nutr Cancer | Serum Nutritional Markers as Prognostic Factors for Hepatic and Extrahepatic Carcinogenesis in Japanese Patients with Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10207 | 31433166 | Biochemistry | A Panel of Protein Kinase Chemosensors Distinguishes Different Types of Fatty Liver Disease. | 2019 | Details |
| A10208 | 31432447 | Hepatol Int | Association of epicardial adipose tissue with non-alcoholic fatty liver disease: a meta-analysis. | 2019 | Details |
| A10209 | 31431413 | HPB (Oxford) | Non-alcoholic fatty liver disease after liver transplantation in patients with non-alcoholic steatohepatitis and cryptogenic cirrhosis: the impact of pre-transplant graft steatosis. | 2019 | Details |
| A10210 | 31430977 | Int J Mol Sci | Paraoxonase-1 as a Regulator of Glucose and Lipid Homeostasis: Impact on the Onset and Progression of Metabolic Disorders. | 2019 | Details |
| A10211 | 31430628 | Clin Neurol Neurosurg | Spinal epidural lipomatosis is associated with liver fat deposition and dysfunction. | 2019 | Details |
| A10212 | 31430456 | Eur J Pharmacol | Pinolenic acid ameliorates oleic acid-induced lipogenesis and oxidative stress via AMPK/SIRT1 signaling pathway in HepG2 cells. | 2019 | Details |
| A10213 | 31430314 | PLoS One | Non-invasive assessment of portal hypertension by multi-parametric magnetic resonance imaging of the spleen: A proof of concept study. | 2019 | Details |
| A10214 | 31430204 | Am J Physiol Endocrinol Metab | Hypoxia exacerbates nonalcoholic fatty liver disease via the HIF-2α/PPARα pathway. | 2019 | Details |
| A10215 | 31428351 | Food Sci Nutr | Lactobacillus paracasei Jlus66 extenuate oxidative stress and inflammation via regulation of intestinal flora in rats with non alcoholic fatty liver disease. | 2019 | Details |
| A10216 | 31428204 | Diabetol Metab Syndr | Incidence and risk factors for metabolic syndrome among urban, adult Sri Lankans: a prospective, 7-year community cohort, follow-up study. | 2019 | Details |
| A10217 | 31428049 | Front Endocrinol (Lausanne) | The Liver in Children With Metabolic Syndrome. | 2019 | Details |
| A10218 | 31426291 | Int J Mol Sci | Antioxidant Versus Pro-Apoptotic Effects of Mushroom-Enriched Diets on Mitochondria in Liver Disease. | 2019 | Details |
| A10219 | 31425963 | Diabetes Metab Syndr | Prevalence and predictors of non-alcoholic fatty liver disease in prediabetes. | 2019 | Details |
| A10220 | 31425956 | Diabetes Metab Syndr | A review of synbiotic efficacy in non-alcoholic fatty liver disease as a therapeutic approach. | 2019 | Details |